MedPath

甘肃河西制药有限责任公司

Ownership
-
Established
2004-11-12
Employees
-
Market Cap
-
Website
http://www.gshxzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

214

NMPA:214

Drug Approvals

杞菊地黄丸

Approval Number
国药准字Z62020431
Approval Date
Oct 22, 2024
NMPA

感冒清热颗粒

Approval Number
国药准字Z62020938
Approval Date
Oct 22, 2024
NMPA

保和丸

Approval Number
国药准字Z62020948
Approval Date
Oct 22, 2024
NMPA

藿香正气丸

Approval Number
国药准字Z20027337
Approval Date
Oct 22, 2024
NMPA

肉蔻四神丸

Approval Number
国药准字Z62020198
Approval Date
Oct 22, 2024
NMPA

前列泰片

Approval Number
国药准字Z20073003
Approval Date
Oct 22, 2024
NMPA

板蓝根颗粒

Approval Number
国药准字Z62020945
Approval Date
Oct 22, 2024
NMPA

参苏丸

Approval Number
国药准字Z62020196
Approval Date
Oct 22, 2024
NMPA

沉香化滞丸

Approval Number
国药准字Z62020972
Approval Date
Oct 22, 2024
NMPA

防风通圣丸

Approval Number
国药准字Z62020930
Approval Date
Oct 22, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 22
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.